FDA Grants Emergency Use Authorization to Third COVID-19 Antibody Therapy
May 27th, 2021—After the emergency use authorization of antibody therapies from Regeneron, and Eli Lilly, the USFDA today has approved a third one today. GSK and Vir Biotechnology’s sotrovimab has …
Read More